Bristol-Myers hepatitis C drug gets approval in Japan

July 7 Mon Jul 7, 2014 7:41am EDT

July 7 (Reuters) - Bristol-Myers Squibb and Co said its combination drug for the treatment of hepatitis C was approved in Japan.

The treatment, which comprises Daklinza and Sunvepra drugs, is meant for patients who are intolerant or have failed to respond to standard medication. (Reporting By Penumudi Amrutha in Bangalore; Editing by Don Sebastian)

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article